Plasma D-Dimer Is a Promising Marker to Guide Timing of Reimplantation: A Prospective Cohort Study
The Journal of Arthroplasty · 2023
DOI: 10.1016/j.arth.2023.04.065 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Arthroplasty, 2023. Verfasst von Saad Tarabichi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Hemostatics, Arthritis, Infectious. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Two-stage exchange arthroplasty remains the preferred surgical treatment for chronic periprosthetic joint infection. Currently, there is no single reliable marker to determine the optimal timing for reimplantation. The purpose of this prospective study was to assess the diagnostic utility of plasma D-dimer and other serological markers in predicting successful control of infection following reimplantation. METHODS: This study enrolled 136 patients undergoing reimplantation arthroplasty between November 2016 and December 2020. Strict inclusion criteria were applied including the need for a two-week "antibiotic holiday" prior to reimplantation. A total of 114 patients were included in the final analysis. Plasma D-dimer, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and fibrinogen were measured preoperatively. Treatment success was defined using the Musculoskeletal Infection Society Outcome-Reporting Tool. Receiver operating characteristic curves were used to assess the prognostic accuracy of each biomarker in predicting failure following reimplantation at a minimum 1-year follow-up. RESULTS: Treatment failure occurred in 33 patients (28.9%) at a mean follow-up of 3.2 years (range, 1.0 to 5.7). Median plasma D-dimer was significantly higher in the treatment failure group (1,604 versus 631 ng/mL, P < .001), whereas median CRP, ESR, and fibrinogen were not significantly different between the success and failure groups. Plasma D-dimer demonstrated the best diagnostic utility (area under the curve [AUC] 0.724, sensitivity 51.5%, specificity 92.6%), outperforming ESR (AUC 0.565, sensitivity 93.3%, specificity 22.5%), CRP (AUC 0.541, sensitivity 87.5%, specificity 26.3%), and fibrinogen (AUC 0.485, sensitivity 30.4%, specificity 80.0%). Plasma D-dimer level of ≥1,604 ng/mL was identified as the optimal cutoff that predicted failure following reimplantation. CONCLUSION: Plasma D-dimer was superior to serum ESR, CRP, and fibrinogen in predicting failure after the second stage of a two-stage exchange arthroplasty for periprosthetic joint infection. Based on the findings of this prospective study, plasma D-dimer may be a promising marker in assessing the control of infection in patients undergoing reimplantation surgery. LEVEL OF EVIDENCE: Level II.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania; Plan de Estudios Combinados en Medicina (PECEM) MD/PhD, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico Cit…
Zitieren
APA
Tarabichi, S., Goh, G. S., Fernández-Rodríguez, D., Baker, C. M., Lizcano, J. D., & Parvizi, J. (2023). Plasma D-Dimer Is a Promising Marker to Guide Timing of Reimplantation: A Prospective Cohort Study. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.04.065
Vancouver
Tarabichi S, Goh GS, Fernández-Rodríguez D, Baker CM, Lizcano JD, Parvizi J. Plasma D-Dimer Is a Promising Marker to Guide Timing of Reimplantation: A Prospective Cohort Study. The Journal of Arthroplasty. 2023. doi:10.1016/j.arth.2023.04.065
BibTeX
@article{Tarabichi2023,
author = {Tarabichi, Saad and Goh, Graham S and Fernández-Rodríguez, Diana and Baker, Colin M and Lizcano, Juan D and Parvizi, Javad},
title = {Plasma D-Dimer Is a Promising Marker to Guide Timing of Reimplantation: A Prospective Cohort Study},
journal = {The Journal of Arthroplasty},
year = {2023},
doi = {10.1016/j.arth.2023.04.065}
}
EUVIMED